Resmed announced the election of Nicole Mowad-Nassar to its board of directors and the upcoming retirement of Rich Sulpizio.
Nicole Mowad-Nassar, currently Senior Vice President at AbbVie, brings over 30 years of expertise in the pharmaceutical and healthcare industry, focusing on digital innovation.
Rich Sulpizio, a board member since 2005, will retire following the 2025 Annual Meeting of Stockholders after two decades of contributions to Resmed.
Nicole Mowad-Nassar's Appointment
Brings over 30 years of strategic, commercial, and operational expertise in the pharmaceutical and broader healthcare industry, with a focus on digital innovation.
Rich Sulpizio's Retirement
Sulpizio will retire from the board following the 2025 Annual Meeting after serving since 2005, bringing energy, candor, and mentorship to the boardroom.
- Nicole Mowad-Nassar's appointment adds new dimensions of thought and broad healthcare delivery experience to Resmed's board.
- Rich Sulpizio's retirement marks the end of two decades of contributions to Resmed, leaving a legacy of mentorship and leadership in the tech and healthcare industry.
The addition of Nicole Mowad-Nassar and the retirement of Rich Sulpizio mark significant changes for Resmed's board of directors, bringing in new expertise and bidding farewell to a longstanding contributor.